WindRose Health Investors recapitalizes Versistat Group

Veristat provides essential services along the entire clinical therapeutic development spectrum through regulatory approval and post-approval.

7 April 2021•3 mins read
Feature image
LinkedInXEmail
LinkedInXEmail

Related articles